139 related articles for article (PubMed ID: 18256346)
1. Meningococcal A vaccination response is enhanced by acute stress in men.
Edwards KM; Burns VE; Adkins AE; Carroll D; Drayson M; Ring C
Psychosom Med; 2008 Feb; 70(2):147-51. PubMed ID: 18256346
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.
Wing JB; Smart L; Borrow R; Findlow J; Findlow H; Heath AW; Read RC
Clin Infect Dis; 2011 Jun; 52(11):1317-23. PubMed ID: 21596673
[TBL] [Abstract][Full Text] [Related]
3. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
Pace D
Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
[TBL] [Abstract][Full Text] [Related]
7. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
[TBL] [Abstract][Full Text] [Related]
8. The association between life events, social support, and antibody status following thymus-dependent and thymus-independent vaccinations in healthy young adults.
Phillips AC; Burns VE; Carroll D; Ring C; Drayson M
Brain Behav Immun; 2005 Jul; 19(4):325-33. PubMed ID: 15944072
[TBL] [Abstract][Full Text] [Related]
9. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
10. Immunization strategies for the control of serogroup C meningococcal disease in developed countries.
De Wals P
Expert Rev Vaccines; 2006 Apr; 5(2):269-75. PubMed ID: 16608426
[TBL] [Abstract][Full Text] [Related]
11. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
Backhouse JL; Gidding HF; MacIntyre CR; McIntyre PB; Gilbert GL
Vaccine; 2007 Jan; 25(7):1310-5. PubMed ID: 17069937
[TBL] [Abstract][Full Text] [Related]
12. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
Kshirsagar N; Mur N; Thatte U; Gogtay N; Viviani S; Préziosi MP; Elie C; Findlow H; Carlone G; Borrow R; Parulekar V; Plikaytis B; Kulkarni P; Imbault N; LaForce FM
Vaccine; 2007 Sep; 25 Suppl 1():A101-7. PubMed ID: 17532101
[TBL] [Abstract][Full Text] [Related]
13. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients.
Yu JW; Borkowski A; Danzig L; Reiter S; Kavan P; Mazer BD
Pediatr Blood Cancer; 2007 Dec; 49(7):918-23. PubMed ID: 17366523
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B.
Davenport V; Groves E; Horton RE; Hobbs CG; Guthrie T; Findlow J; Borrow R; Naess LM; Oster P; Heyderman RS; Williams NA
J Infect Dis; 2008 Sep; 198(5):731-40. PubMed ID: 18636953
[TBL] [Abstract][Full Text] [Related]
15. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.
de Voer RM; van der Klis FR; Engels CW; Rijkers GT; Sanders EA; Berbers GA
Clin Vaccine Immunol; 2008 Aug; 15(8):1188-93. PubMed ID: 18550729
[TBL] [Abstract][Full Text] [Related]
16. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination.
Gomez-Lus ML; Giménez MJ; Vázquez JA; Aguilar L; Anta L; Berrón S; Laguna B; Prieto J
Infection; 2003 Jan; 31(1):51-4. PubMed ID: 12590334
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
Guirola M; Carmenate T; Menéndez T; Alvarez A; González S; Guillén G
J Microbiol Methods; 2006 Apr; 65(1):135-43. PubMed ID: 16122825
[TBL] [Abstract][Full Text] [Related]
18. Acute stress exposure prior to influenza vaccination enhances antibody response in women.
Edwards KM; Burns VE; Reynolds T; Carroll D; Drayson M; Ring C
Brain Behav Immun; 2006 Mar; 20(2):159-68. PubMed ID: 16102936
[TBL] [Abstract][Full Text] [Related]
19. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
